Patterns of Medical Marijuana Use Among Individuals Sampled from Medical Marijuana Dispensaries in Los Angeles

Journal of Psychoactive Drugs

Volumn 46, Issue 4, 2014, Pages 263-272

  Grella, Christine E ^a   Rodriguez, Luz ^a   Kim, Tina ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Los Angeles County Department of Public Health Substance Abuse Prevention and Control Program   (United States)

Author keywords

alcohol and drug use; dispensaries; focus group; health status; medical marijuana; survery

Indexed keywords

ILLICIT DRUG; MEDICAL CANNABIS;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS USE; CLINICAL ARTICLE; CLINICAL FEATURE; DISTRESS SYNDROME; DRUG MISUSE; DRUG TRAFFIC; FEMALE; HEALTH; HEALTH CARE SURVEY; HUMAN; MALE; PHARMACY; QUESTIONNAIRE; TOBACCO USE; ALCOHOLISM; ATTITUDE TO HEALTH; CALIFORNIA; CANNABIS ADDICTION; CANNABIS SMOKING; HEALTH BEHAVIOR; HEALTH CARE FACILITY; HEALTH STATUS; INFORMATION PROCESSING; MENTAL HEALTH; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR; SMOKING; TRENDS; YOUNG ADULT;

ADULT; ALCOHOLISM; FEMALE; FOCUS GROUPS; HEALTH BEHAVIOR; HEALTH FACILITIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; LOS ANGELES; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MEDICAL MARIJUANA; MENTAL HEALTH; MIDDLE AGED; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84926044937     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2014.944960     Document Type: Article

References (41)

1. Anderson, D.M. & Rees, D.I. 2014a. The legalization of recreational marijuana: How likely is the worst case scenario? Journal of Policy Analysis and Management 33 (1): 221–32.
2. Anderson, D.M. & Rees, D.I. 2014b. The role of dispensaries: The devil is in the details. Journal of Policy Analysis and Management 33 (1): 235–40.
3. Babson, K.A.; Boden, M.T. & Bonn-Miller, M.O. 2013. Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. American Journal of Drug and Alcohol Abuse 39 (3): 211–6.
4. Boden, M.T.; Gross, J.J.; Babson, K.A. & Bonn-Miller, M.O. 2013. The interactive effects of emotional clarity and cognitive reappraisal on problematic cannabis use among medical cannabis users. Addictive Behaviors 38 (3): 1663–8.
5. Bonn-Miller, M.O.; Boden, M.T.; Bucossi, M.M. & Babson, K.A. 2014. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. American Journal of Drug and Alcohol Abuse 40 (1): 23–30.
6. Bonn-Miller, M.O. & Zvolensky, M.J. 2009. An evaluation of the nature of marijuana use and its motives among young adult active users. American Journal on Addictions 18 (5): 409–16.
7. Borgelt, L.M.; Franson, K.L.; Nussbaum, A.M. & Wang, G.S. 2013. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33 (2): 195–209.
8. Bostwick, J.M. 2012. Blurred boundaries: The therapeutics and politics of medical marijuana. Mayo Clinic Proceedings 87 (2): 172–86.
9. Bottorff, J.L.; Bissell, L.J.; Balneaves, L.G.; Oliffe, J.L.; Kang, H.B.; Capler, N.R.; Buxton, J.A. & O’Brien, R.K. 2011. Health effects of using cannabis for therapeutic purposes: A gender analysis of users’ perspectives. Substance Use & Misuse 46 (6): 769–80.
10. Boyatzis, R.E. 1998. Thematic Analysis and Code Development: Transforming Qualitative Information. Thousand Oaks, CA: Sage.
11. Burns, R.M.; Caulkins, J.P.; Everingham, S.S. & Kilmer, B. 2013. Statistics on cannabis users skew perceptions of cannabis use. Frontiers in Psychiatry 4: 138.
12. Cerda, M.; Wall, M.; Keyes, K.M.; Galea, S. & Hasin, D. 2012. Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug and Alcohol Dependence 120 (1–3): 22–7.
13. Conway, K.P.; Compton, W.; Stinson, F.S. & Grant, B.F. 2006. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67 (2): 247–57.
14. Degenhardt, L.; Coffey, C.; Carlin, J.B.; Swift, W.; Moore, E. & Patton, G.C. 2010. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. British Journal of Psychiatry 196: 290–5.
15. Dennis, M. L., Chan, Y.-F. & Funk, R. 2006. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing, and substance use disorders and crime/violence problems among adolescents and adults. American Journal on Addictions 15 (suppl. 1): s80–s91.
16. Dennis, M.L.; Feeney, T. & Titus J.C. 2013. Global Appraisal of Individual Needs–Short Screener (GAIN-SS): Administration and Scoring Manual, Version 3. Bloomington, IL: Chestnut Health Systems.
17. Feldman, H.W. & Mandel, J. 1998. Providing medical marijuana: The importance of cannabis clubs. Journal of Psychoactive Drugs 30 (2): 179–86.
18. Furler, M.D.; Einarson, T.R.; Millson, M.; Walmsley, S. & Bendayan, R. 2004. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care and STDs 18 (4): 215–28.
19. Glaser, B.G. & Strauss, A.L. 1967. The Discovery of Grounded Theory: Strategies for Qualitative Research. New Brunswick, NJ: Aldine de Gruyter.
20. Hall, W. & Degenhardt, L. 2014. The adverse health effects of chronic cannabis use. Drug Testing & Analysis 6 (1–2): 39–45.
21. Harris, D.; Jones, R.T.; Shank, R.; Nath, R.; Fernandez, E.; Goldstein, K. & Mendelson, J. 2000. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases 19 (3): 89–103.
22. Indlekofer, F.; Piechatzek, M.; Daamen, M.; Glasmacher, C.; Lieb, R.; Pfister H. & Schütz, C.G. 2009. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. Journal of Psychopharmacology 23: 495–509.
23. Janichek, J.L. & Reiman, A. 2012. Clinical service desires of medical cannabis patients. Harm Reduction Journal 9: 12.
24. Kepple, N.J. & Freisthler, B. 2012. Exploring the ecological association between crime and medical marijuana dispensaries. Journal of Studies on Alcohol and Drugs 73 (4): 523–30.
25. Kleber, H.D. & DuPont, R.L. 2012. Physicians and medical marijuana. American Journal of Psychiatry 169 (6): 564–8.
26. Nunberg, H.; Kilmer, B.; Pacula, R.L. & Burgdorf, J.R. 2011. An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis 4 (1): 1–16.
27. O’Connell, T.J. & Bou-Matar, C.B. 2007. Long term marijuana users seeking medical cannabis in California (2001-2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal 4: 16.
28. Pacula R.L. & Sevigny, E.L. 2014a. Marijuana liberalization policies: Why we can’t learn much from policy still in motion. Journal of Policy Analysis and Management 33(1): 212–21.
29. Pacula R.L. & Sevigny, E.L. 2014b. Natural experiments in a complex and dynamic environment: The need for a measured assessment of the evidence. Journal of Policy Analysis and Management 33(1): 232–5.
30. Peters, E.N.; Budney, A.J. & Carroll, K.M. 2012. Clinical correlates of co-occurring cannabis and tobacco use: A systematic review. Addiction 107 (8): 1404–17.
31. Pew Charitable Trust. 2013. Majority now supports legalized marijuana. Available at: http://www.people-press.org/2013/04/04/majority-now-supports-legalizing-marijuana/.
32. Prentiss, D.; Power, R.; Balmas, G.; Tzuang, G. & Israelski, D.M. 2004. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. Journal of Acquired Immune Deficiency Syndromes 35 (1): 38–45.
33. Reiman A. 2007. Medical cannabis patients: Patient profiles and health care utilization patterns. Complementary Health Practice Review 12 (1): 31–50.
34. Reiman, A. 2008. Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California. Health & Social Care in the Community 16 (1): 31–41.
35. Reiman, A. 2009. Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 6: 35.
36. Reinarman, C.; Nunberg, H.; Lanthier, F. & Heddleston, T. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 43: 128–35.
37. Substance Abuse and Mental Health Services Administration. 2013. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available at: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm#ch5.3
38. Swift, W.; Coffey, C., Degenhardt, L.; Carlin, J.B.; Romaniuk, H. & Patton, G.C. 2012. Cannabis and progression to other substance use in young adults: Findings from a 13-year prospective population-based study. Journal of Epidemiology and Community Health 66: e26.
39. Temple, E.C.; Brown, R.F. & Hine, D.W. 2011. The “grass ceiling”: Limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction 106 (2): 238–44.
40. Wittchen, H.; Fröhlich, C.; Behrendt, S.; Günther, A.; Rehm, J.; Zimmermann, P. & Perkonigg, A. 2007. Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents. Drug and Alcohol Dependence 88: S60–S70.
41. Wittchen, H.-U.; Behrendt, S.; Höfler, M.; Perkonigg, A.; Rehm, J.; Lieb, R. & Beesdo, K. 2009. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs. Drug and Alcohol Dependence 102: 151–7.